Suramin in Treating Patients With Recurrent Primary Brain Tumors

NCT00002639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: chemotherapy
DRUG: suramin

Sponsor

Emory University

Collaborators

[object Object]